<DOC>
	<DOCNO>NCT00916422</DOCNO>
	<brief_summary>The objective trial ass clinical efficacy modify extract ( depigmented polymerise glutaraldehyde ) subcutaneous injection Phleum pratense pollen treatment patient affect allergic rhinitis/ rhinoconjunctivitis ( without episodic asthma ) induce hypersensitivity grass pollen , evaluate Score regard Symptoms consumption medication .</brief_summary>
	<brief_title>Subcutaneous Immunotherapy Treatment Patients With Hypersensitivity Grass Pollen</brief_title>
	<detailed_description>Immunotherapy specific treatment allergic disease . Unlike conventional pharmacological treatment , immunotherapy treatment could modify natural course allergic disease . This prospective double-blind placebo control study two arm treatment up-dosing cluster regimen 4 week .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Informed consent , sign subject . Clinical History moderate severe rhinitis/rhinoconjunctivitis last least 2 consecutive year , without episodic asthma , cause allergy grass pollen . Patient gender age 18 55 Symptoms coincide allergy grass pollen Sensitivity grass pollen , diagnose positive skin reaction Phleum pratense : Positive prick test /or Specific IgE P.pratense &gt; 0,7KU/L Patients include must monosensitised , case polysensitisation , sensitivity p.pratense pollen consider relevant aspect condition clinical standpoint . Patients able comply dose regime Patient mild Rhinitis/rhinoconjunctivitis Relevant sensitivity another perennial allergen Use immunotherapy last four year Treatment B . Blocking agent Patient suffer pathology adrenalin contraindicate Subject suffers serious medical condition , would interference treatment follow subject study Subject suffer autoimmune disease ( thyroiditis , lupus , etc . ) Conditions patient offer full cooperation significant psychiatric disorder . Intolerance aspirin Pregnant woman pregnancy risk breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Immunotherapy</keyword>
	<keyword>Allergoid</keyword>
	<keyword>Depigmented</keyword>
	<keyword>Polymerized</keyword>
	<keyword>Allergen-extract</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
</DOC>